Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma

Psaila B, Lyden D (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9:285–293

Previdi S, Maroni P, Matteucci E, Broggini M, Bendinelli P, Desiderio MA (2010) Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways. Eur J Cancer 46:1679–1691

Bendinelli P, Matteucci E, Maroni P, Desiderio MA (2009) NF-kB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Mol Cancer Res 7:1328–1341

Chiodoni C, Colombo MP, Sangaletti S (2010) Matricellular proteins: from homeostasis to inflammation, cancer and metastasis. Cancer Metastasis Rev 29:295–307

Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239–252

Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549

Weigelt B, Peterse JL, van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602

Klein A, Olendrowitz C, Schmutzler R, Hampl J, Schlag PM, Mass N et al (2009) Identification of brain- and bone-specific breast cancer metastasis genes. Cancer Lett 276:212–220

Kopfstein L, Christofori G (2006) Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. CMLS Cell Mol Life Sci 63:449–468

Ridolfi E, Matteucci E, Maroni P, Desiderio MA (2008) Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. Br J Cancer 99:1623–1634

Kingsley LA, Fournier PG, Chirgwin JM, Guise TA (2007) Molecular biology of bone metastasis. Mol Cancer Ther 6:2609–2617

Fry CJ, Farnham PJ (1999) Context-dependent transcriptional regulation. J Biol Chem 274:29583–29586

Lee YH, Suzuki YJ, Griffin AJ, Day RM (2008) Hepatocyte growth factor regulates cyclooxygenase-2 expression via β-catenin, Akt, and p42/p44 MAPK in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 294:L778–L786

Semenza GL (2001) HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167–171

Tacchini L, Dansi P, Matteucci E, Desiderio MA (2001) Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22:1363–1371

Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T (2006) Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res 66:2067–2073

Singh B, Berry JA, Shoher A, Ayers GD, Wei C, Lucci A (2007) COX-2 involvement in breast cancer metastasis to bone. Oncogene 26:3789–3796

Li Z, Schem C, Shi YH, Medina D, Zhang M (2008) Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis. Clin Exp Metastasis 25:389–400

Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3:347–361

Desiderio MA (2007) Hepatocyte growth factor in invasive growth of carcinomas. CMLS Cell Mol Life Sci 64:1341–1354

Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540–550

Shim H, Lau SK, Devi S, Yoon Y, Cho HT, Liang Z (2006) Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1α. Biochem Biophys Res Commun 346:252–258

Yoshitake N, Fukui H, Yamagishi H, Sekikawa A, Fujii S, Tomita S et al (2008) Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 98:1682–1689

Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8:S62–S67

Chen HH, Su WC, Lin PW, Guo HR, Lee WY (2007) Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer. Breast Cancer Res Treat 103:167–175

Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al (1999) Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59:5830–5835

Matteucci E, Bendinelli P, Desiderio MA (2009) Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells. Carcinogenesis 30:937–945

Lepourcelet M, Chen Y-N, France DS, Wang H, Crews P, Petersen F et al (2004) Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell 5:91–102

Yue L, Christman JW, Mazzone T (2008) Tumor necrosis factor-alpha-mediated suppression of adipocyte apolipoprotein E gene transcription: primary role for the nuclear factor (NF)-kappaB pathway and NFkappaB p50. Endocrinology 149:4051–4058

Lu X, Yan CH, Yuan M, Wei Y, Hu G, Kang Y (2010) In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer. Cancer Res 70:3905–3914

Dunn LK, Mohammad KS, Fournier PG, McKenna CR, Davis HW, Niewolna M et al (2009) Hypoxia and TGF-β drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. Plos ONE 4:1–20

Moore AE, Greenhough A, Roberts HR, Hicks DJ, Patsos HA, Williams AC et al (2009) HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis 30:1796–1804

Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF et al (2002) Prostaglandin E2 induces hypoxia-inducible factor-1α stabilization and nuclear localization in human prostate cancer cell line. J Biol Chem 277:50081–50086

Eliasson P, Jönsson J-I (2009) The hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell Physiol 222:17–22

Lisy K, Peet DJ (2008) Turn me on: regulating HIF transcriptional activity. Cell Death Differ 15:642–649

Parfenova H, Parfenov VN, Shlopov BV, Levine V, Falkos S, Pourcyrous M et al (2001) Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells. Am J Physiol Cell Physiol 281:C166–C178

Wilson CL, Thomsen J, Hoivik DJ, Wormke MT, Stanker L, Holtzapple C et al (1997) Aryl hydrocarbon (Ah) nonresponsiveness in estrogen receptor-negative MDA-MB231 cells is associated with expression of variant Arnt protein. Arch Biochem Biophys 346:65–73

Hirschfeld M, zur Hausen A, Bettendorf H, Jäger M, Stickeler E (2009) Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer. Cancer Res 69:2082–2090

Perrone G, Zagami M, Altomare V, Battista C, Morini S, Rabitti C (2007) COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast. Virchows Arch 451:1039–1045

Singh-Ranger G, Salhab M, Mokbel K (2008) The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res Treat 109:189–198

Li J-J, Lu J, Kaur C, Sivakumar V, Wu C-Y, Ling E-A (2008) Effects of hypoxia on expression of transforming growth factor-β 1 and its receptors I and II in the amoeboid microglial cells and BV-2 cells. Neuroscience 156:662–672

Roman-Blas JA, Stokes DG, Jimenez SA (2007) Modulation of TGF-β signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthr Cartil 15:1367–1377

Chua YS, Chua YL, Hagen T (2010) Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity. Mol Cancer Ther 9:224–235

Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Diff 15:678–685

Marignol L, Coffey M, Lawler M, Hollywood D (2008) Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev 34:313–327

Lin H-Y, Davis PJ, Tang H-Y, Mousa SA, Luidens MK, Hecherbergs AH et al (2009) The pro-apoptotic action of stilbene-induced COX-2 in cancer cell: convergence with the anti-apoptotic effect of thyroid hormone. Cell Cycle 8:1877–1882

Schmid BC, Rudas M, Rezniczek GA, Leodolter S, Zeillinger R (2004) CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia. Breast Cancer Res Treat 84:247–250

Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA et al (2005) Stromal cell-derived factor-1α and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65:6178–6188

Matsumoto K, Nakamura T (2006) Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119:477–483